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  EVIDENCE-BASED ANSWER 
No single nicotine replacement therapy is most effective for all smokers. All forms of nicotine replacement 
therapy (gum, transdermal patch, spray, inhaler, and lozenge) are equally effective, increasing smoking 
cessation rates by about 150% to 200%.1,2 
A Cochrane Review found that 17% of smokers who had used nicotine replacement therapy successfully quit 
at follow-up vs 10% of smokers in the control group.1 Except in special circumstances (medical 
contraindications, smoking <10 cigarettes daily, pregnancy, or breastfeeding), all smokers attempting to quit 
should be offered nicotine replacement therapy (strength of recommendation [SOR]: A).3 
Higher doses of nicotine gum or lozenge (4 mg vs 2 mg) increase quit rates in heavy smokers.1,2 Use of high-
dose patches (>21 mg) may benefit heavy smokers or those relapsing due to nicotine withdrawal (SOR: B).3 
For relapsed smokers, combination therapy improves long-term abstinence rates (estimated abstinence 28.6% 
vs 17.4% for monotherapy) (SOR: B).3 
  EVIDENCE SUMMARY 
A Cochrane Review of 110 trials evaluating the efficacy of nicotine replacement therapy in 35,600 smokers 
found higher quit rates among heavy smokers using 4-mg compared with 2-mg nicotine gum (odds ratio [OR], 
2.67; 95% confidence interval [CI], 1.69–4.22).1 However, patients often chew too few pieces of nicotine gum 
daily, resulting in underdosing.3 Smokers should use the gum on a fixed schedule (at least 1 piece every 1 to 2 
hours).3 
The Cochrane Review finds borderline evidence of a small benefit in abstinence rates (OR, 1.21; 95% CI, 
1.03–1.42) with higher-dose nicotine patches (>21 mg/24 hr or 15 mg/16 hr) for heavy or relapsed smokers.1 
Combining methods that maintain constant drug levels (transdermal patch) with those having more rapid 
effects (gum, spray, inhaler, lozenge) is more effective than monotherapy (OR, 1.9; 95% CI, 1.3–2.6).3 Reserve 
combination therapy for smokers who relapse following monotherapy. 
Regarding concerns about weight gain, all nicotine replacement therapies delay but do not prevent weight gain. 
There is a dose-response relationship between nicotine gum and weight gain: smokers who use more gum 
gain less weight.3 Although abstinence rates are comparable across the 5 available forms of nicotine 
replacement, smokers unwilling to give up oral and behavioral rituals of smoking may perceive the inhaler as 
being more helpful (Table 1).4 
Decisions about the best form of therapy can be based on patient preference, on degree of nicotine 
dependence (a FagerstrÖm Test of Nicotine Dependence Scale score ≥5 [Table 2], or habitually smoking the 
first cigarette within 30 minutes of awakening),5 or nicotine replacement therapy history, which includes number 
and outcome of previous quit attempts, specific method used, duration, side effects, and proper usage. 
  RECOMMENDATIONS FROM OTHERS 
The Cochrane Review states: “All of the commercially available forms of nicotine replacement therapy are 
effective as part of a strategy to promote smoking cessation. They increase quit rates approximately 1.5 to 2 
fold regardless of setting. Use of nicotine replacement therapy should be preferentially directed to smokers 
who are motivated to quit, and have high levels of nicotine dependency. Choice of which form to use should 
reflect patient needs, tolerability and cost considerations. Patches are likely to be easier to use than gum or 
nasal spray in primary care settings.”1 
The US Department of Health and Human Services Clinical Practice Guideline states: “All patients attempting 
to quit should be encouraged to use effective pharmacotherapies for smoking cessation except in the presence 
of special circumstances.”3 Heavy smokers should use 4-mg nicotine gum. Combining the nicotine patch with a 
self-administered form of nicotine replacement therapy (gum or nicotine nasal spray) is more efficacious than a 
single form of therapy. Patients should be encouraged to use combined treatments if unable to quit using a 
single form of first-line pharmacotherapy.3 
 
TABLE 1 
Nicotine replacement therapy selection guide 
  
Moderate 
smokers (10–
20 
cigarettes/d) 
Heavy 
smokers (>30 
cigarettes/d) 
Weight 
concerns 
Gum   
(4 mg vs 2 mg 
gum enhances 
quit rates) 
(All nicotine 
replacement 
therapies delay 
weight gain, 
specifically 
nicotine gum) 
Transdermal 
patch 
  
(Small benefit 
of dosing >21 
mg) 
  
Inhaler       
Nasal spray       
Lozenge   
(Reserve 4 mg 
for heavy 
smokers) 
  
Combination       
 
TABLE 2 
FagerstrÖm test for level of nicotine dependence (abridged) 
How soon after waking 
do you smoke first 
cigarette? 
  ______ Points 
 Less than 5 minutes: 3 
points 
    
 5 to 30 minutes: 2 points     
 31 to 60 minutes: 1 point     
How many cigarettes do 
you smoke per day? 
  ______ Points 
 More than 30 per day: 3 
points 
    
 21 to 30 per day: 2 points     
 11 to 20 per day: 1 point     
    ______ Total Points 
Interpretation 
 Total points 
Level of 
dependence 
Nictotine 
replacement therapy 
 5–6 points 
heavy nicotine 
dependence 
consider 21-mg 
nicotine patch 
 3–4 points moderate nicotine consider 14-mg 
dependence nicotine patch 
 0–2 points 
light nicotine 
dependence 
consider 7-mg nicotine 
patch or no patch 
CLINICAL COMMENTARY 
Erik  Lindbloom,  MD, MSPH 
Department of Family and Community Medicine, University of Missouri–Columbia 
Now that nicotine replacement therapy is available over the counter, prescribers may not 
consider or discuss delivery options with patients as much as they did in the past. As this 
Clinical Inquiry illustrates, there are situations when one approach may be recommended 
over another. 
For example, the relapsed smoker who has tried 1 nicotine replacement product may not 
even be aware that other methods, including combination therapy, are possible. 
Considering the enormous potential health improvement that is achieved through smoking 
cessation, this may be one of the most important topics to revisit regularly with patients. 
R E F E R E N C E S  
1. Silagy  C, Lancaster  T, Stead  L, Mant  D, Fowler  G. Nicotine replacement therapy 
for smoking cessation.  The Cochrane Library, Volume (Issue 4), 2002. 
2. Shiffman  S, Dresler  CM, Hajek  P, Gilburt  SJ, Targett  DA, Strahs  KR. Efficacy of 
a nicotine lozenge for smoking cessation.  Arch Intern Med 2002;162:1267–1276. 
3. Fiore  MC, Bailey  WC, Cohen  SJ , et al.  Treating Tobacco Use and Dependence. 
Clinical Practice Guideline.  Rockville, Md: US Dept of Health and Human Services, 
Public Health Service, June 2000. 
4. Schneider  NG, Olmstead  R, Nilsson  F, Vaghaiwalla Mody  F, Franzon  M, Doan  
K. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-
controlled trial.  Addiction 1996;91:1293–1306. 
5. Heatherton  TF, Kozlowski  LT, Frecker  RC, FagerstrÖm  KO. The FagerstrÖm 
Test for Nicotine Dependence: a revision of the FagerstrÖm Tolerance 
Questionnaire.  Br J Addict 1991;86:1119–1127. 
 
